These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17683060)

  • 1. Agglomerative crystallization of ABT-510 in a partially miscible solvent system.
    Sheikh AY; Pal A; Viswanath S; Tolle JC
    J Pharm Sci; 2008 Mar; 97(3):1202-12. PubMed ID: 17683060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of antisolvent crystallization of sodium scutellarein by combined FBRM-PVM-NIR.
    Liu X; Sun D; Wang F; Wu Y; Chen Y; Wang L
    J Pharm Sci; 2011 Jun; 100(6):2452-9. PubMed ID: 21246557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spherical Crystallization Based on Liquid-Liquid Phase Separation in a Reverse Antisolvent Crystallization Process.
    Gong W; Li P; Rohani S
    J Pharm Sci; 2024 Jun; 113(6):1616-1623. PubMed ID: 38311170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of binder liquid type on spherical crystallization.
    Maghsoodi M; Hajipour A
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1468-75. PubMed ID: 23937581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing crystalline properties of a cardiovascular active pharmaceutical ingredient using a process analytical technology based crystallization feedback control strategy.
    Saleemi AN; Steele G; Pedge NI; Freeman A; Nagy ZK
    Int J Pharm; 2012 Jul; 430(1-2):56-64. PubMed ID: 22449455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic droplet liquid reactors for active pharmaceutical ingredient crystallization by diffusion controlled solvent extraction.
    Tona RM; McDonald TAO; Akhavein N; Larkin JD; Lai D
    Lab Chip; 2019 Jun; 19(12):2127-2137. PubMed ID: 31114833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisolvent membrane crystallization of pharmaceutical compounds.
    Di Profio G; Stabile C; Caridi A; Curcio E; Drioli E
    J Pharm Sci; 2009 Dec; 98(12):4902-13. PubMed ID: 19655372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Wet Milling Combined with Temperature Cycling to Minimize Crystal Agglomeration in a Sequential Antisolvent-Cooling Crystallization.
    Sun Z; Quon JL; Papageorgiou CD; Benyahia B; Rielly CD
    Cryst Growth Des; 2022 Aug; 22(8):4730-4744. PubMed ID: 35942120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
    Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-line monitoring and interpretation of an indomethacin anti-solvent crystallization process by near-infrared spectroscopy (NIRS).
    Lee HE; Lee MJ; Kim WS; Jeong MY; Cho YS; Choi GJ
    Int J Pharm; 2011 Nov; 420(2):274-81. PubMed ID: 21907779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spherical crystallization of drugs.
    Kovačič B; Vrečer F; Planinšek O
    Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous synthesis of polymer-coated drug particles by porous hollow fiber membrane-based antisolvent crystallization.
    Chen D; Singh D; Sirkar KK; Pfeffer R
    Langmuir; 2015; 31(1):432-41. PubMed ID: 25552289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
    Dong Y; Ng WK; Hu J; Shen S; Tan RB
    Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process intensification of atorvastatin calcium crystallization for target polymorph development via continuous combined cooling and antisolvent crystallization using an oscillatory baffled crystallizer.
    Kshirsagar S; Lakshmi Ramana Susarla N; Ramakrishnan S; Nagy ZK
    Int J Pharm; 2022 Nov; 627():122172. PubMed ID: 36084877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex methodology for rational design of Apremilast-benzoic acid co-crystallization process.
    Jirát J; Ondo D; Babor M; Ridvan L; Šoóš M
    Int J Pharm; 2019 Oct; 570():118639. PubMed ID: 31465834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Batch cooling crystallization and pressure filtration of sulphathiazole: the influence of solvent composition.
    Häkkinen A; Pöllänen K; Karjalainen M; Rantanen J; Louhi-Kultanen M; Nyström L
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):17-28. PubMed ID: 15283678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing Crystal Agglomeration of Pharmaceutical Crystals Using Temperature Cycling and a Novel Membrane Crystallization Procedure for Seed Crystal Generation.
    Simone E; Othman R; Vladisavljević GT; Nagy ZK
    Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29364167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.